Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB 1 receptors

By Wagner J.A.   Kunos G.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 203-210

Elsevier

Access to resources Recommend Favorite

Relationship between Cannabinoid CB₁ and Dopamine D₂ Receptors in Intestinal Motility in Mice

By Carai M.A.M.   Agabio R.   Lobina C.   Pani M.   Reali R.   Vacca G.   Colombo G.   Gessa G.L.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 287-291

Pharmaceutical Press

Access to resources Recommend Favorite

CB1 Cannabinoid Receptors and their Associated Proteins

By  

Current Medicinal Chemistry, Vol. 17, Iss. 14, 2010-05 ,pp. : 1382-1393

Bentham Science Publishers

Access to resources Recommend Favorite

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB 1 /CB 2 receptors

By Brooks J.W.   Pryce G.   Bisogno T.   Jaggar S.I.   Hankey D.J.R.   Brown P.   Bridges D.   Ledent C.   Bifulco M.   Rice A.S.C.   Di Marzo V.   Baker D.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 83-92

Elsevier

Access to resources Recommend Favorite

Pharmacological characterisation of cannabinoid CB 1 receptors in the rat and mouse

By Lay L.   Angus J.A.   Wright C.E.  

European Journal of Pharmacology, Vol. 391, Iss. 1, 2000-03 ,pp. : 151-161

Elsevier

Access to resources Recommend Favorite